Kohler Co. Launches Safe Water for All to Address Global Water and Sanitation Crisis

Thu, 10/01/2020 - 09:10

Kohler Co. today announced the launch of Safe Water For All, an initiative to further address pressing issues around water access, quality, and conservation and broaden public awareness around water issues.

Biomimicry Innovation: change:WATER Labs

Thu, 10/01/2020 - 10:30

change:WATER Labs is changing the way humans process waste, and it all has to do with water. They recognized that if water is removed from human waste, all that's left is a compact solid that would be much easier to collect and sterilize.

The Power of Stories to Transform Lives

Mon, 10/05/2020 - 14:00

OLON Continues Strategic Collaboration With Novartis, Supporting the Expansion of the Africa Sickle Cell Disease Program to Kenya, Uganda and Tanzania

Thu, 10/01/2020 - 07:00

OLON announced it will continue its collaboration with Novartis to support the Africa Sickle Cell Disease program as it expands to Kenya, Uganda and Tanzania.

CRB's SlateXpace™ Gives Cell and Gene Therapy Clients New Flexibility, Control Over Manufacturing Needs To Support Highly Complex Product Pipelines

Wed, 09/30/2020 - 09:00

Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time. Today, a pioneering multi-modality manufacturing solution addresses that challenge: SlateXpace™.

New Sensory Room at New Hope Middle School 'a Safe Space' for Special Needs Students

Wed, 09/30/2020 - 16:35

New Hope Middle School officially opened its new Kodiak Calming Cove, a sensory room for children with special needs, recently, and "it'll make a big difference for students to have a safe space they can go into," said Belinda Sloan, the school's principal.

Life Science Companies and the Bill & Melinda Gates Foundation: Commitments to Expanded Global Access for COVID-19 Diagnostics, Therapeutics, and Vaccines

Wed, 09/30/2020 - 01:05

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

Mon, 09/28/2020 - 16:35

Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

Using Science to Do Our Part in Greenhouse Gas Reduction at Hershey

Wed, 10/07/2020 - 13:30

Hershey has been working to reduce our greenhouse gas emissions (GHG) for a decade now as part of our broader belief in reducing our impact on the planet. More recently, Hershey committed to the Science Based Targets Initiative (SBTi) in January 2019 to develop a science-based greenhouse gas reduction goal by January 2021.

Factories, Face Masks and the New Back To School

Tue, 09/29/2020 - 12:00